Growth Factors Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ÁÖ¿ä ÀλçÀÌÆ®
2024³â ¼ºÀåÀÎÀÚ ½ÃÀå ±Ô¸ð(2024³â) : 22¾ï ´Þ·¯
½ÃÀå ±Ô¸ð ¿¹Ãø(2031³â) : 33¾ï ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(2024-2031³â) : CAGR 5.8%
½ÃÀå ÃËÁø¿äÀÎ:
¼ºÀåÀÎÀÚ ½ÃÀåÀº ÁÖ·Î ¾Ï, ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ÷´Ü Ä¡·á ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÑ »óȲ¿¡¼ ¼ºÀåÀÎÀÚ ½ÃÀåÀÌ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¼ºÀåÀÎÀڴ ǥÀû Ä¡·á¿Í Àç»ý ÀÇÇп¡¼ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, Á¶Á÷ °øÇÐ ¹× »óó Ä¡À¯¿¡ ´ëÇÑ Àû¿ëÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. »ý¸í°øÇÐ ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀº ÀçÁ¶ÇÕ ¼ºÀåÀÎÀÚÀÇ »ý»ê¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ Á¢±Ù¼º°ú È¿´ÉÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°èÀûÀ¸·Î °í·ÉȰ¡ ÁøÇàµÇ¸é¼ Çõ½ÅÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ÂÃãÇü ÀÇ·áÀÇ ¹ßÀüÀº Á¤¹Ð Ä¡·á¿¡¼ ¼ºÀåÀÎÀÚÀÇ ÀáÀç·ÂÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.
½ÃÀå ¾ïÁ¦¿äÀÎ:
ÁÁÀº ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, ¼¼°è ¼ºÀåÀÎÀÚ ½ÃÀåÀº ¸î °¡Áö µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀçÁ¶ÇÕ ¼ºÀåÀÎÀÚÀÇ »ý»ê ¹× »ó¾÷È¿¡ µû¸¥ ³ôÀº ºñ¿ëÀº ƯÈ÷ ºñ¿ë¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡¼ ±× º¸±ÞÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦ À庮°ú ±î´Ù·Î¿î ½ÂÀÎ ÀýÂ÷´Â Á¦Ç° Ãâ½Ã¸¦ Áö¿¬½ÃŰ°í ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï±¹ ½ÃÀå¿¡¼´Â ¼ºÀåÀÎÀÚÀÇ Ä¡·áÀû Àû¿ë¿¡ ´ëÇÑ ÀνÄÀÌ ³·°í, ´ëü Ä¡·á¹ý°úÀÇ °æÀïÀº ½ÃÀå ¼ºÀå¿¡ ¶Ç ´Ù¸¥ µµÀüÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ:
Àç»ýÀÇ·á ¹× ¸¸¼ºÁúȯ °ü¸® ºÐ¾ß¿¡¼ ¼ºÀåÀÎÀÚÀÇ »õ·Î¿î ¿ëµµ °³¹ßÀº Å« ¼ºÀå ±âȸ¸¦ °¡Áö°í ÀÖ½À´Ï´Ù. Á¾¾ç ¹× ¸ÂÃãÀÇ·á¿Í °°Àº ½ÅÈï ºÐ¾ß·Î ¼ºÀåÀÎÀÚ¸¦ È®´ëÇÏ´Â °ÍÀº ±â¼ú Çõ½ÅÀÇ »õ·Î¿î ±æÀ» ¿¾îÁÙ °ÍÀÔ´Ï´Ù. »ý¸í°øÇÐ ±â¾÷, ¿¬±¸±â°ü, ÀÇ·á ¼ºñ½º Á¦°øÀÚ °£ÀÇ Çù·ÂÀû ³ë·ÂÀº ÀÌ ºÐ¾ßÀÇ ¹ßÀüÀ» °¡¼ÓÈÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, Á¤¹ÐÀÇ·áÀÇ µµÀÔÀº ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ß´ÞÇÑ ¼±Áø Áö¿ª¿¡¼ Å« ½ÃÀå °³Ã´ °¡´É¼ºÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ÀÇ·á ÅõÀÚ È®´ë¿¡ ÈûÀÔÀº ½ÅÈï±¹ÀÇ ¹Ì°³Ã´ ½ÃÀåÀº ¶Ç ´Ù¸¥ À¯¸ÁÇÑ ¼ºÀå ºÐ¾ß·Î ²ÅÈü´Ï´Ù.
¼¼°è ¼ºÀåÀÎÀÚ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ Á¤ÀÇ¿Í °³¿ä, ½ÃÀå ÃËÁø¡¤¾ïÁ¦¿äÀÎ, °¢Á¾ µ¿Çâ, ½ÃÀå ±âȸ¿Í °úÁ¦, ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ÀϺΠ¼ö·®) ÃßÀÌ¿Í ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ȯ°æ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
½ÃÀå ¿ªÇÐ
ÃßÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
°úÁ¦
ÁÖ¿ä µ¿Çâ
°Å½Ã°æÁ¦ ¿äÀÎ
COVID-19ÀÇ ¿µÇ⠺м®
¿¹Ãø¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ
Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®
±ÔÁ¦ »óȲ
Á¦Ç° ä¿ë ºÐ¼®
¹ë·ùüÀÎ ºÐ¼®
ÁÖ¿ä °Å·¡¿Í ÇÕº´
PESTLE ºÐ¼®
Porter's Five Forces ºÐ¼®
Á¦4Àå ¼¼°èÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå Àü¸Á : ÃßÀÌ¿Í ¿¹Ãø
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð¡¤Àü³âºñ ¼ºÀå·ü
¼öÀÍ ±âȸ
½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø
¼¼°è ½ÃÀå Àü¸Á : Á¦Ç°º°
¼¼°è ½ÃÀå Àü¸Á : µî±Þº°
¼¼°è ½ÃÀå Àü¸Á : ¿ëµµº°
¼¼°è ½ÃÀå Àü¸Á : ¹ßÇö È£½ºÆ® ½Ã½ºÅÛº°
¼¼°è ½ÃÀå Àü¸Á : ÀÛ¿ë±âÀüº°
¼¼°è ½ÃÀå Àü¸Á : À¯·¡ Á¾º°
¼¼°è ½ÃÀå Àü¸Á : ÃÖÁ¾»ç¿ëÀÚº°
Á¦5Àå ¼¼°èÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå Àü¸Á : Áö¿ªº°
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð ÃßÁ¤
½ÃÀå ±Ô¸ð ¿¹Ãø
ºÏ¹Ì
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ª
Á¦6Àå ºÏ¹ÌÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå Àü¸Á : ÃßÀÌ¿Í ¿¹Ãø
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð ÃßÁ¤
±¹°¡º°
Á¦Ç°º°
µî±Þº°
¿ëµµº°
¹ßÇö È£½ºÆ® ½Ã½ºÅÛº°
ÀÛ¿ë±âÀüº°
À¯·¡ Á¾º°
ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ±¹°¡º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : Á¦Ç°º°
Àüȯ¼ºÀåÀÎÀÚ(TGF)
Ç¥ÇǼºÀåÀÎÀÚ(EGF)
Ç÷¼ÒÆÇ À¯·¡ ¼ºÀåÀÎÀÚ(PDGF)
¼¶À¯¾Æ¼¼Æ÷ Áõ½ÄÀÎÀÚ(FGF)
Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ(IGF)
Ç÷°ü³»ÇǼºÀåÀÎÀÚ(VEGF)
°£¼¼Æ÷ Áõ½ÄÀÎÀÚ(HGF)
Á¾¾ç±«»çÀÎÀÚ(TNF)
ÀÎÅÍ·ùŲ
±âŸ
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : µî±Þº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¿ëµµº°
Á¾¾ç
Ç÷¾×
»óó Ä¡À¯
ÇǺΰú
½ÉÇ÷°üÁúȯ¡¤´ç´¢º´
¼¼Æ÷ Ä¡·á¡¤Ã¼¿Ü Á¦Á¶
±âŸ
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¹ßÇö È£½ºÆ® ½Ã½ºÅÛº°
µ¿¹° À¯·¡ ¼ºÀåÀÎÀÚ
ÀçÁ¶ÇÕ ¼ºÀåÀÎÀÚ
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÀÛ¿ë±âÀüº°
Ç÷°ü½Å»ý ¼ºÀåÀÎÀÚ
Ç× ¾ÆÆ÷Åä½Ã½º ¼ºÀåÀÎÀÚ
ºÐ¿ ÃËÁø ¼ºÀåÀÎÀÚ
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : À¯·¡ Á¾º°
Àΰ£
µÅÁö
¸¶¿ì½º
·¡Æ®
±âŸ
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°
Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
¿¬±¸ ¼¾ÅÍ¡¤Çмú±â°ü
CRO
½ÃÀå ¸Å·Â ºÐ¼®
Á¦7Àå À¯·´ÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå Àü¸Á : ÃßÀÌ¿Í ¿¹Ãø
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð ÃßÁ¤
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ±¹°¡º°
µ¶ÀÏ
ÇÁ¶û½º
¿µ±¹
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
·¯½Ã¾Æ
ÅÍŰ
±âŸ
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : Á¦Ç°º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : µî±Þº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¿ëµµº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¹ßÇö È£½ºÆ® ½Ã½ºÅÛº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÀÛ¿ë±âÀüº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : À¯·¡ Á¾º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ¸Å·Â ºÐ¼®
Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå Àü¸Á : ÃßÀÌ¿Í ¿¹Ãø
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð ÃßÁ¤
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ±¹°¡º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : Á¦Ç°º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : µî±Þº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¿ëµµº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¹ßÇö È£½ºÆ® ½Ã½ºÅÛº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÀÛ¿ë±âÀüº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : À¯·¡ Á¾º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ¸Å·Â ºÐ¼®
Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå Àü¸Á : ÃßÀÌ¿Í ¿¹Ãø
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð ÃßÁ¤
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ±¹°¡º°
Àεµ
µ¿³²¾Æ½Ã¾Æ
È£ÁÖ
±âŸ
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : Á¦Ç°º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : µî±Þº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¿ëµµº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¹ßÇö È£½ºÆ® ½Ã½ºÅÛº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÀÛ¿ë±âÀüº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : À¯·¡ Á¾º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ¸Å·Â ºÐ¼®
Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå Àü¸Á : ÃßÀÌ¿Í ¿¹Ãø
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð ÃßÁ¤
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ±¹°¡º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : Á¦Ç°º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : µî±Þº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¿ëµµº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¹ßÇö È£½ºÆ® ½Ã½ºÅÛº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÀÛ¿ë±âÀüº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : À¯·¡ Á¾º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ¸Å·Â ºÐ¼®
Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼ºÀåÀÎÀÚ ½ÃÀå Àü¸Á : ÃßÀÌ¿Í ¿¹Ãø
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ±Ô¸ð ÃßÁ¤
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ±¹°¡º°
GCC ±¹°¡
ÀÌÁýÆ®
³²¾ÆÇÁ¸®Ä«°øÈ±¹
ºÏ¾ÆÇÁ¸®Ä«
±âŸ
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : Á¦Ç°º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : µî±Þº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¿ëµµº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ¹ßÇö È£½ºÆ® ½Ã½ºÅÛº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÀÛ¿ë±âÀüº°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : À¯·¡ Á¾º°
½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ¸Å·Â ºÐ¼®
Á¦12Àå °æÀï ±¸µµ
½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀå ±¸Á¶
±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
Thermo Fisher Scientific, Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Lonza Group AG
F. Hoffmann-La Roche Ltd.
Sartorius CellGenix GmbH
Bio-Techne Corporation
GenScript
Miltenyi Biotec.
Abcam PLC
Sino Biological Inc.
Cell Signaling Technology, Inc.
ACROBiosystems
Becton, Dickinson, and Company
Creative Bioarray
Applied Biological Materials(abm) Inc.
GE Healthcare
Meridian Bioscience Inc.
Repligen Corporation
Aviva Systems Biology Corporation(GenWay Biotech)
Leadgene Biomedical, Inc.
Boster Bio
Prospec-Tany Technogene Ltd.
Proteintech Group, Inc.
AJINOMOTO CO.,INC
STEMCELL Technologies
Akron Biotech
PeproTech Inc.
Á¦13Àå ºÎ·Ï
ksm
Persistence Market Research has recently released a comprehensive report on the global Growth Factors Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions
Key Insights:
Growth Factors Market Size (2024E): US$ 2.2 Bn
Projected Market Value (2031F): US$ 3.3 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 5.8%
Growth Factors Market - Report Scope:
The global growth factors market comprises biologically active proteins or peptides that play essential roles in cell proliferation, differentiation, and tissue regeneration. These compounds are increasingly being used in regenerative medicine, oncology, and chronic disease management. The market's growth trajectory is influenced by innovations in biotechnology, enabling the production of recombinant growth factors with enhanced efficacy and scalability. The market also benefits from supportive government initiatives, rising investments in biomedical research, and the increasing prevalence of chronic diseases worldwide.
Market Drivers:
The growth factors market is primarily driven by the rising prevalence of chronic diseases such as cancer and diabetes, necessitating advanced therapeutic solutions. Growth factors play a pivotal role in targeted therapies and regenerative medicine, further driving their adoption in tissue engineering and wound healing applications. Technological advancements in biotechnology have revolutionized the production of recombinant growth factors, enhancing their accessibility and effectiveness. Additionally, the global aging population is creating a surge in demand for innovative therapeutic approaches. Government initiatives and increased funding for biomedical research provide further impetus to the market, while advancements in personalized medicine amplify the potential of growth factors in precision therapies.
Market Restraints:
Despite the favorable growth prospects, the global growth factors market faces several challenges. The high costs associated with the production and commercialization of recombinant growth factors can hinder their widespread adoption, particularly in cost-sensitive markets. Regulatory hurdles and stringent approval processes can delay product launches, impacting market growth. Furthermore, limited awareness about the therapeutic applications of growth factors in developing regions and competition from alternative treatment modalities pose additional challenges for the market.
Market Opportunities:
Significant growth opportunities exist in the development of novel applications for growth factors in regenerative medicine and chronic disease management. The expansion of growth factors into emerging fields such as oncology and personalized medicine opens up new avenues for innovation. Collaborative efforts between biotechnology firms, research institutions, and healthcare providers are expected to accelerate advancements in this domain. Moreover, the increasing adoption of precision medicine presents substantial market potential, particularly in developed regions with advanced healthcare infrastructure. Untapped markets in emerging economies, supported by growing healthcare investments, represent another promising growth area for the market.
Key Questions Answered in the Report:
What are the primary factors driving the global growth of the growth factors market?
Which therapeutic areas are gaining the highest adoption across different regions?
How are advancements in biotechnology shaping the competitive landscape of the growth factors market?
Who are the key players in the growth factors market, and what strategies are they employing to maintain their market positions?
What are the emerging trends and future outlooks for the global growth factors market?
Competitive Intelligence and Business Strategy:
Leading companies in the global growth factors market, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, and Lonza Group AG, are focusing on innovations in biotechnology to maintain their competitive edge. These players are leveraging advancements in recombinant technology to develop highly efficacious growth factors for targeted therapies and regenerative applications. Partnerships between pharmaceutical companies and academic research institutions are driving research and accelerating commercialization timelines. Companies are also emphasizing affordability and accessibility to cater to a broader patient population while aligning with global healthcare goals.
Key Companies Profiled:
Thermo Fisher Scientific, Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Lonza Group AG
F. Hoffmann-La Roche Ltd.
Sartorius CellGenix GmbH
Bio-Techne Corporation
GenScript
Miltenyi Biotec.
Abcam PLC
Sino Biological Inc.
Cell Signaling Technology, Inc.
ACROBiosystems
Becton, Dickinson, and Company
Creative Bioarray
Applied Biological Materials (abm) Inc.
GE Healthcare
Meridian Bioscience Inc.
Repligen Corporation
Aviva Systems Biology Corporation (GenWay Biotech)
Leadgene Biomedical, Inc.
Boster Bio
Prospec-Tany Technogene Ltd.
Proteintech Group, Inc.
AJINOMOTO CO., Inc.
STEMCELL Technologies
Akron Biotech
PeproTech Inc.
Growth Factors Market Segmentation:
By Product
Transforming Growth Factors (TGF)
Epidermal Growth Factors (EGFs)
Platelet-derived Growth Factors (PDGFs)
Fibroblast Growth Factors (FGFs)
Insulin-like Growth Factors (IGFs)
Vascular Endothelial Growth Factors (VEGFs)
Hepatocyte Growth Factors (HGFs)
Tumor Necrosis Factors (TNFs)
Interleukins
Others
By Grade
By Application
Oncology
Hematology
Wound Healing
Dermatology
Cardiovascular Disease and Diabetes
Cell Therapy and EX-vivo Manufacturing
Others
By Expression Host System
Animal-derived
Recombinant
By Mode of Action
Angiogenic
Anti-apoptotic
Mitogenic
By Species Origin
Human
Pig
Mouse
Rat
Others
By End User
Pharmaceutical and Biotechnology Companies
Research Centers and Academic Institutes
Contract Research Organizations
By Region
North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa
Table of Contents
1. Executive Summary
1.1. Global Growth Factors Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis
4. Global Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
4.3. Global Growth Factors Market Outlook: Product
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019 - 2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
4.3.3.1. Transforming Growth Factors (TGF)
4.3.3.1.1. Activin
4.3.3.1.2. Bone Morphogenetic Proteins (BMPs)
4.3.3.1.3. TGF-beta Proteins
4.3.3.2. Epidermal Growth Factors (EGFs)
4.3.3.3. Platelet-Derived Growth Factors (PDGFs)
4.3.3.4. Fibroblast Growth Factors (FGFs)
4.3.3.5. Insulin-like Growth Factors (IGFs)
4.3.3.6. Vascular Endothelial Growth Factors (VEGFs)
4.3.3.7. Hepatocyte Growth Factors (HGFs)
4.3.3.8. Tumor Necrosis Factors (TNFs)
4.3.3.9. Interleukins
4.3.3.10. Others
4.3.4. Market Attractiveness Analysis: Product
4.4. Global Growth Factors Market Outlook: Grade
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Grade, 2019 - 2023
4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
4.4.3.1. GMP Grade
4.4.3.2. NON-GMP Grade
4.4.4. Market Attractiveness Analysis: Grade
4.5. Global Growth Factors Market Outlook: Application
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
4.5.3.1. Oncology
4.5.3.2. Hematology
4.5.3.3. Wound Healing
4.5.3.4. Dermatology
4.5.3.5. Cardiovascular Disease & Diabetes
4.5.3.6. Cell Therapy & EX-vivo Manufacturing
4.5.3.7. Others
4.5.4. Market Attractiveness Analysis: Application
4.6. Global Growth Factors Market Outlook: Expression Host System
4.6.1. Introduction / Key Findings
4.6.2. Historical Market Size (US$ Bn) Analysis, By Expression Host System, 2019 - 2023
4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
4.6.3.1. Animal Derived
4.6.3.2. Recombinant
4.6.4. Market Attractiveness Analysis: Expression Host System
4.7. Global Growth Factors Market Outlook: Mode of Action
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Bn) Analysis, By Mode of Action, 2019 - 2023
4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
4.7.3.1. Angiogenic
4.7.3.2. Anti-apoptotic
4.7.3.3. Mitogenic
4.7.4. Market Attractiveness Analysis: Mode of Action
4.8. Global Growth Factors Market Outlook: Species Origin
4.8.1. Introduction / Key Findings
4.8.2. Historical Market Size (US$ Bn) Analysis, By Species Origin, 2019 - 2023
4.8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
4.8.3.1. Human
4.8.3.2. Pig
4.8.3.3. Mouse
4.8.3.4. Rat
4.8.3.5. Others
4.8.4. Market Attractiveness Analysis: Species Origin
4.9. Global Growth Factors Market Outlook: End User
4.9.1. Introduction / Key Findings
4.9.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
4.9.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
4.9.3.1. Pharmaceutical and Biotechnology Companies
4.9.3.2. Research Centers & Academic Institutes
4.9.3.3. Contract Research Organizations
4.9.4. Market Attractiveness Analysis: End User
5. Global Growth Factors Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
6.2.1. By Country
6.2.2. By Product
6.2.3. By Grade
6.2.4. By Application
6.2.5. By Expression Host System
6.2.6. By Mode of Action
6.2.7. By Species Origin
6.2.8. By End User
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
6.4.1. Transforming Growth Factors (TGF)
6.4.1.1. Activin
6.4.1.2. Bone Morphogenetic Proteins (BMPs)
6.4.1.3. TGF-beta Proteins
6.4.2. Epidermal Growth Factors (EGFs)
6.4.3. Platelet-Derived Growth Factors (PDGFs)
6.4.4. Fibroblast Growth Factors (FGFs)
6.4.5. Insulin-like Growth Factors (IGFs)
6.4.6. Vascular Endothelial Growth Factors (VEGFs)
6.4.7. Hepatocyte Growth Factors (HGFs)
6.4.8. Tumor Necrosis Factors (TNFs)
6.4.9. Interleukins
6.4.10. Others
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
6.5.1. GMP Grade
6.5.2. NON-GMP Grade
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
6.6.1. Oncology
6.6.2. Hematology
6.6.3. Wound Healing
6.6.4. Dermatology
6.6.5. Cardiovascular Disease & Diabetes
6.6.6. Cell Therapy & EX-vivo Manufacturing
6.6.7. Others
6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
6.7.1. Animal-Derived Growth Factors
6.7.2. Recombinant Growth Factors
6.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
6.8.1. Angiogenic Growth Factors
6.8.2. Anti-Apoptotic Growth Factors
6.8.3. Mitogenic Growth Factors
6.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
6.9.1. Human
6.9.2. Pig
6.9.3. Mouse
6.9.4. Rat
6.9.5. Others
6.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
6.10.1. Pharmaceutical and Biotechnology Companies
6.10.2. Research Centers & Academic Institutes
6.10.3. Contract Research Organizations
6.11. Market Attractiveness Analysis
7. Europe Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
7.2.1. By Country
7.2.2. By Product
7.2.3. By Grade
7.2.4. By Application
7.2.5. By Expression Host System
7.2.6. By Mode of Action
7.2.7. By Species Origin
7.2.8. By End User
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkey
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
7.4.1. Transforming Growth Factors (TGF)
7.4.1.1. Activin
7.4.1.2. Bone Morphogenetic Proteins (BMPs)
7.4.1.3. TGF-beta Proteins
7.4.2. Epidermal Growth Factors (EGFs)
7.4.3. Platelet-Derived Growth Factors (PDGFs)
7.4.4. Fibroblast Growth Factors (FGFs)
7.4.5. Insulin-like Growth Factors (IGFs)
7.4.6. Vascular Endothelial Growth Factors (VEGFs)
7.4.7. Hepatocyte Growth Factors (HGFs)
7.4.8. Tumor Necrosis Factors (TNFs)
7.4.9. Interleukins
7.4.10. Others
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
7.5.1. GMP Grade
7.5.2. NON-GMP Grade
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
7.6.1. Oncology
7.6.2. Hematology
7.6.3. Wound Healing
7.6.4. Dermatology
7.6.5. Cardiovascular Disease & Diabetes
7.6.6. Cell Therapy & EX-vivo Manufacturing
7.6.7. Others
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
7.7.1. Animal-Derived Growth Factors
7.7.2. Recombinant Growth Factors
7.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
7.8.1. Angiogenic Growth Factors
7.8.2. Anti-Apoptotic Growth Factors
7.8.3. Mitogenic Growth Factors
7.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
7.9.1. Human
7.9.2. Pig
7.9.3. Mouse
7.9.4. Rat
7.9.5. Others
7.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
7.10.1. Pharmaceutical and Biotechnology Companies
7.10.2. Research Centers & Academic Institutes
7.10.3. Contract Research Organizations
7.11. Market Attractiveness Analysis
8. East Asia Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
8.2.1. By Country
8.2.2. By Product
8.2.3. By Grade
8.2.4. By Application
8.2.5. By Expression Host System
8.2.6. By Mode of Action
8.2.7. By Species Origin
8.2.8. By End User
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
8.4.1. Transforming Growth Factors (TGF)
8.4.1.1. Activin
8.4.1.2. Bone Morphogenetic Proteins (BMPs)
8.4.1.3. TGF-beta Proteins
8.4.2. Epidermal Growth Factors (EGFs)
8.4.3. Platelet-Derived Growth Factors (PDGFs)
8.4.4. Fibroblast Growth Factors (FGFs)
8.4.5. Insulin-like Growth Factors (IGFs)
8.4.6. Vascular Endothelial Growth Factors (VEGFs)
8.4.7. Hepatocyte Growth Factors (HGFs)
8.4.8. Tumor Necrosis Factors (TNFs)
8.4.9. Interleukins
8.4.10. Others
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
8.5.1. GMP Grade
8.5.2. NON-GMP Grade
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
8.6.1. Oncology
8.6.2. Hematology
8.6.3. Wound Healing
8.6.4. Dermatology
8.6.5. Cardiovascular Disease & Diabetes
8.6.6. Cell Therapy & EX-vivo Manufacturing
8.6.7. Others
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
8.7.1. Animal-Derived Growth Factors
8.7.2. Recombinant Growth Factors
8.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
8.8.1. Angiogenic Growth Factors
8.8.2. Anti-Apoptotic Growth Factors
8.8.3. Mitogenic Growth Factors
8.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
8.9.1. Human
8.9.2. Pig
8.9.3. Mouse
8.9.4. Rat
8.9.5. Others
8.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
8.10.1. Pharmaceutical and Biotechnology Companies
8.10.2. Research Centers & Academic Institutes
8.10.3. Contract Research Organizations
8.11. Market Attractiveness Analysis
9. South Asia & Oceania Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
9.2.1. By Country
9.2.2. By Product
9.2.3. By Grade
9.2.4. By Application
9.2.5. By Expression Host System
9.2.6. By Mode of Action
9.2.7. By Species Origin
9.2.8. By End User
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
9.4.1. Transforming Growth Factors (TGF)
9.4.1.1. Activin
9.4.1.2. Bone Morphogenetic Proteins (BMPs)
9.4.1.3. TGF-beta Proteins
9.4.2. Epidermal Growth Factors (EGFs)
9.4.3. Platelet-Derived Growth Factors (PDGFs)
9.4.4. Fibroblast Growth Factors (FGFs)
9.4.5. Insulin-like Growth Factors (IGFs)
9.4.6. Vascular Endothelial Growth Factors (VEGFs)
9.4.7. Hepatocyte Growth Factors (HGFs)
9.4.8. Tumor Necrosis Factors (TNFs)
9.4.9. Interleukins
9.4.10. Others
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
9.5.1. GMP Grade
9.5.2. NON-GMP Grade
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
9.6.1. Oncology
9.6.2. Hematology
9.6.3. Wound Healing
9.6.4. Dermatology
9.6.5. Cardiovascular Disease & Diabetes
9.6.6. Cell Therapy & EX-vivo Manufacturing
9.6.7. Others
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
9.7.1. Animal-Derived Growth Factors
9.7.2. Recombinant Growth Factors
9.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
9.8.1. Angiogenic Growth Factors
9.8.2. Anti-Apoptotic Growth Factors
9.8.3. Mitogenic Growth Factors
9.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
9.9.1. Human
9.9.2. Pig
9.9.3. Mouse
9.9.4. Rat
9.9.5. Others
9.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
9.10.1. Pharmaceutical and Biotechnology Companies
9.10.2. Research Centers & Academic Institutes
9.10.3. Contract Research Organizations
9.11. Market Attractiveness Analysis
10. Latin America Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
10.2.1. By Country
10.2.2. By Product
10.2.3. By Grade
10.2.4. By Application
10.2.5. By Expression Host System
10.2.6. By Mode of Action
10.2.7. By Species Origin
10.2.8. By End User
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
10.4.1. Transforming Growth Factors (TGF)
10.4.1.1. Activin
10.4.1.2. Bone Morphogenetic Proteins (BMPs)
10.4.1.3. TGF-beta Proteins
10.4.2. Epidermal Growth Factors (EGFs)
10.4.3. Platelet-Derived Growth Factors (PDGFs)
10.4.4. Fibroblast Growth Factors (FGFs)
10.4.5. Insulin-like Growth Factors (IGFs)
10.4.6. Vascular Endothelial Growth Factors (VEGFs)
10.4.7. Hepatocyte Growth Factors (HGFs)
10.4.8. Tumor Necrosis Factors (TNFs)
10.4.9. Interleukins
10.4.10. Others
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
10.5.1. GMP Grade
10.5.2. NON-GMP Grade
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
10.6.1. Oncology
10.6.2. Hematology
10.6.3. Wound Healing
10.6.4. Dermatology
10.6.5. Cardiovascular Disease & Diabetes
10.6.6. Cell Therapy & EX-vivo Manufacturing
10.6.7. Others
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
10.7.1. Animal-Derived Growth Factors
10.7.2. Recombinant Growth Factors
10.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
10.8.1. Angiogenic Growth Factors
10.8.2. Anti-Apoptotic Growth Factors
10.8.3. Mitogenic Growth Factors
10.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
10.9.1. Human
10.9.2. Pig
10.9.3. Mouse
10.9.4. Rat
10.9.5. Others
10.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
10.10.1. Pharmaceutical and Biotechnology Companies
10.10.2. Research Centers & Academic Institutes
10.10.3. Contract Research Organizations
10.11. Market Attractiveness Analysis
11. Middle East & Africa Growth Factors Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
11.2.1. By Country
11.2.2. By Product
11.2.3. By Grade
11.2.4. By Application
11.2.5. By Expression Host System
11.2.6. By Mode of Action
11.2.7. By Species Origin
11.2.8. By End User
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2023 - 2031
11.4.1. Transforming Growth Factors (TGF)
11.4.1.1. Activin
11.4.1.2. Bone Morphogenetic Proteins (BMPs)
11.4.1.3. TGF-beta Proteins
11.4.2. Epidermal Growth Factors (EGFs)
11.4.3. Platelet-Derived Growth Factors (PDGFs)
11.4.4. Fibroblast Growth Factors (FGFs)
11.4.5. Insulin-like Growth Factors (IGFs)
11.4.6. Vascular Endothelial Growth Factors (VEGFs)
11.4.7. Hepatocyte Growth Factors (HGFs)
11.4.8. Tumor Necrosis Factors (TNFs)
11.4.9. Interleukins
11.4.10. Others
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Grade, 2023 - 2031
11.5.1. GMP Grade
11.5.2. NON-GMP Grade
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
11.6.1. Oncology
11.6.2. Hematology
11.6.3. Wound Healing
11.6.4. Dermatology
11.6.5. Cardiovascular Disease & Diabetes
11.6.6. Cell Therapy & EX-vivo Manufacturing
11.6.7. Others
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Expression Host System, 2023 - 2031
11.7.1. Animal-Derived Growth Factors
11.7.2. Recombinant Growth Factors
11.8. Current Market Size (US$ Bn) Analysis and Forecast, By Mode of Action, 2023 - 2031
11.8.1. Angiogenic Growth Factors
11.8.2. Anti-Apoptotic Growth Factors
11.8.3. Mitogenic Growth Factors
11.9. Current Market Size (US$ Bn) Analysis and Forecast, By Species Origin, 2023 - 2031
11.9.1. Human
11.9.2. Pig
11.9.3. Mouse
11.9.4. Rat
11.9.5. Others
11.10. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
11.10.1. Pharmaceutical and Biotechnology Companies
11.10.2. Research Centers & Academic Institutes
11.10.3. Contract Research Organizations
11.11. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Thermo Fisher Scientific, Inc.
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Merck KGaA
12.3.3. Bio-Rad Laboratories, Inc.
12.3.4. Lonza Group AG
12.3.5. F. Hoffmann-La Roche Ltd.
12.3.6. Sartorius CellGenix GmbH
12.3.7. Bio-Techne Corporation
12.3.8. GenScript
12.3.9. Miltenyi Biotec.
12.3.10. Abcam PLC
12.3.11. Sino Biological Inc.
12.3.12. Cell Signaling Technology, Inc.
12.3.13. ACROBiosystems
12.3.14. Becton, Dickinson, and Company
12.3.15. Creative Bioarray
12.3.16. Applied Biological Materials (abm) Inc.
12.3.17. GE Healthcare
12.3.18. Meridian Bioscience Inc.
12.3.19. Repligen Corporation
12.3.20. Aviva Systems Biology Corporation (GenWay Biotech)
12.3.21. Leadgene Biomedical, Inc.
12.3.22. Boster Bio
12.3.23. Prospec-Tany Technogene Ltd.
12.3.24. Proteintech Group, Inc.
12.3.25. AJINOMOTO CO.,INC
12.3.26. STEMCELL Technologies
12.3.27. Akron Biotech
12.3.28. PeproTech Inc.
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations